TipRanks
Centene (CNC)
NYSE:CNC
US Market
CNC
Centene
RESEARCH TOOLSreports
Want to see CNC full AI Analyst Report?

Centene (CNC) Stock Forecast & Price Target

3,076 Followers
See the Price Targets and Ratings of:

CNC Analyst Ratings

Moderate Buy
14Ratings
Moderate Buy
6 Buy
8 Hold
0 Sell
Based on 14 analysts giving stock ratings to
Centene
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CNC Stock 12 Month Forecast

Average Price Target

$72.92
▲(12.19% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $72.92 with a high forecast of $80.00 and a low forecast of $65.00. The average price target represents a 12.19% change from the last price of $65.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"32":"$32","81":"$81","44.25":"$44.3","56.5":"$56.5","68.75":"$68.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$80.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":72.92307692307692,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$72.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$65.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[32,44.25,56.5,68.75,81],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.99,62.45230769230769,63.91461538461539,65.37692307692308,66.83923076923077,68.30153846153846,69.76384615384616,71.22615384615385,72.68846153846154,74.15076923076923,75.61307692307692,77.07538461538462,78.53769230769231,{"y":80,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.99,61.907928994082845,62.82585798816568,63.74378698224852,64.66171597633137,65.5796449704142,66.49757396449704,67.41550295857988,68.33343195266272,69.25136094674556,70.1692899408284,71.08721893491123,72.00514792899408,{"y":72.92307692307692,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.99,61.29846153846154,61.60692307692308,61.91538461538462,62.223846153846154,62.5323076923077,62.84076923076923,63.14923076923077,63.457692307692305,63.76615384615385,64.07461538461538,64.38307692307693,64.69153846153846,{"y":65,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35.74,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.37,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.15,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.95,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.34,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.35,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.22,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.23,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.99,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$80.00Average Price Target$72.92Lowest Price Target$65.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CNC
Ben Hendrix
RBC Capital
RBC Capital
$71
Hold
9.23%
Upside
Reiterated
10/07/26
Centene (CNC) Receives a Hold from RBC Capital
Bernstein Analyst forecast on CNC
Lance Wilkes
Bernstein
Bernstein
$79
Buy
21.54%
Upside
Reiterated
10/05/26
Bernstein Remains a Buy on Centene (CNC)
Bank of America Securities Analyst forecast on CNC
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$80
Buy
23.08%
Upside
Reiterated
09/24/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Barclays Analyst forecast on CNC
Andrew Mok CFA
Barclays
Barclays
$80
Buy
23.08%
Upside
Reiterated
09/17/26
Barclays Sticks to Their Buy Rating for Centene (CNC)
Wells Fargo Analyst forecast on CNC
Stephen Baxter
Wells Fargo
Wells Fargo
$69
Hold
6.15%
Upside
Reiterated
09/15/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Natera (NASDAQ: NTRA) and Vertex Pharmaceuticals (NASDAQ: VRTX)
J.P. Morgan Analyst forecast on CNC
John Stansel
J.P. Morgan
J.P. Morgan
$67
Hold
3.08%
Upside
Assigned
08/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: BioNTech SE (NASDAQ: BNTX) and Centene (NYSE: CNC)
Argus Research Analyst forecast on CNC
John Staszak
Argus Research
Argus Research
$80
Buy
23.08%
Upside
Upgraded
08/10/26
Centene upgraded to Buy from Hold at ArgusCentene upgraded to Buy from Hold at Argus
TD Cowen Analyst forecast on CNC
Ryan Langston
TD Cowen
TD Cowen
$65
Hold
0.00%
Upside
Assigned
07/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC) and Dyne Therapeutics (NASDAQ: DYN)
Truist Financial Analyst forecast on CNC
David S Macdonald
Truist Financial
Truist Financial
$78→$80
Buy
23.08%
Upside
Reiterated
07/29/26
Truist Financial Keeps Their Buy Rating on Centene (CNC)
Morgan Stanley Analyst forecast on CNC
Erin Wright
Morgan Stanley
Morgan Stanley
$57→$66
Hold
1.54%
Upside
Reiterated
07/29/26
Erin Wright Raises Centene Price Target to $66 on Strong Execution but Maintains Hold Amid Sustainability Concerns
UBS Analyst forecast on CNC
A.J. Rice
UBS
UBS
$61→$70
Hold
7.69%
Upside
Reiterated
07/29/26
Centene price target raised to $70 from $61 at UBSCentene price target raised to $70 from $61 at UBS
Robert W. Baird Analyst forecast on CNC
Michael Ha
Robert W. Baird
Robert W. Baird
$46→$66
Hold
1.54%
Upside
Reiterated
07/29/26
Centene price target raised to $66 from $46 at Baird Centene price target raised to $66 from $46 at Baird
Cantor Fitzgerald Analyst forecast on CNC
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$75
Buy
15.38%
Upside
Reiterated
07/28/26
Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Ansell (ANSLF)
Guggenheim Analyst forecast on CNC
Jason Cassorla
Guggenheim
Guggenheim
―
Hold
―
Reiterated
07/28/26
Guggenheim Sticks to Its Hold Rating for Centene (CNC)
Mizuho Securities Analyst forecast on CNC
Ann Hynes
Mizuho Securities
Mizuho Securities
$63→$69
Hold
6.15%
Upside
Reiterated
07/13/26
Mizuho Securities Remains a Hold on Centene (CNC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CNC
Ben Hendrix
RBC Capital
RBC Capital
$71
Hold
9.23%
Upside
Reiterated
10/07/26
Centene (CNC) Receives a Hold from RBC Capital
Bernstein Analyst forecast on CNC
Lance Wilkes
Bernstein
Bernstein
$79
Buy
21.54%
Upside
Reiterated
10/05/26
Bernstein Remains a Buy on Centene (CNC)
Bank of America Securities Analyst forecast on CNC
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
$80
Buy
23.08%
Upside
Reiterated
09/24/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Barclays Analyst forecast on CNC
Andrew Mok CFA
Barclays
Barclays
$80
Buy
23.08%
Upside
Reiterated
09/17/26
Barclays Sticks to Their Buy Rating for Centene (CNC)
Wells Fargo Analyst forecast on CNC
Stephen Baxter
Wells Fargo
Wells Fargo
$69
Hold
6.15%
Upside
Reiterated
09/15/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Natera (NASDAQ: NTRA) and Vertex Pharmaceuticals (NASDAQ: VRTX)
J.P. Morgan Analyst forecast on CNC
John Stansel
J.P. Morgan
J.P. Morgan
$67
Hold
3.08%
Upside
Assigned
08/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: BioNTech SE (NASDAQ: BNTX) and Centene (NYSE: CNC)
Argus Research Analyst forecast on CNC
John Staszak
Argus Research
Argus Research
$80
Buy
23.08%
Upside
Upgraded
08/10/26
Centene upgraded to Buy from Hold at ArgusCentene upgraded to Buy from Hold at Argus
TD Cowen Analyst forecast on CNC
Ryan Langston
TD Cowen
TD Cowen
$65
Hold
0.00%
Upside
Assigned
07/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC) and Dyne Therapeutics (NASDAQ: DYN)
Truist Financial Analyst forecast on CNC
David S Macdonald
Truist Financial
Truist Financial
$78→$80
Buy
23.08%
Upside
Reiterated
07/29/26
Truist Financial Keeps Their Buy Rating on Centene (CNC)
Morgan Stanley Analyst forecast on CNC
Erin Wright
Morgan Stanley
Morgan Stanley
$57→$66
Hold
1.54%
Upside
Reiterated
07/29/26
Erin Wright Raises Centene Price Target to $66 on Strong Execution but Maintains Hold Amid Sustainability Concerns
UBS Analyst forecast on CNC
A.J. Rice
UBS
UBS
$61→$70
Hold
7.69%
Upside
Reiterated
07/29/26
Centene price target raised to $70 from $61 at UBSCentene price target raised to $70 from $61 at UBS
Robert W. Baird Analyst forecast on CNC
Michael Ha
Robert W. Baird
Robert W. Baird
$46→$66
Hold
1.54%
Upside
Reiterated
07/29/26
Centene price target raised to $66 from $46 at Baird Centene price target raised to $66 from $46 at Baird
Cantor Fitzgerald Analyst forecast on CNC
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$75
Buy
15.38%
Upside
Reiterated
07/28/26
Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Ansell (ANSLF)
Guggenheim Analyst forecast on CNC
Jason Cassorla
Guggenheim
Guggenheim
―
Hold
―
Reiterated
07/28/26
Guggenheim Sticks to Its Hold Rating for Centene (CNC)
Mizuho Securities Analyst forecast on CNC
Ann Hynes
Mizuho Securities
Mizuho Securities
$63→$69
Hold
6.15%
Upside
Reiterated
07/13/26
Mizuho Securities Remains a Hold on Centene (CNC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
IMUXImmunic
OMCLOmnicell
LGNDLigand Pharma
KURAKura Oncology
HITIHigh Tide
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Centene

3 Months
Lance WilkesBernstein
Success Rate
18/25 ratings generated profit
72%
Average Return
+9.76%
Copying Lance Wilkes's trades and holding each position for 3 Months would result in 72.00% of your transactions generating a profit, with an average return of +9.76% per trade.
1 Year
Kevin FischbeckBank of America Securities
Success Rate
18/24 ratings generated profit
75%
Average Return
+2.78%
Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +2.78% per trade.
2 Years
Lance WilkesBernstein
Success Rate
20/25 ratings generated profit
80%
Average Return
+38.51%
Copying Lance Wilkes's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +38.51% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CNC Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
17
16
17
17
11
Hold
15
20
17
13
4
Sell
3
0
0
0
0
Strong Sell
0
0
0
0
0
total
35
36
34
30
15
In the current month, CNC has received 11 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CNC average Analyst price target in the past 3 months is 72.92.
Each month's total comprises the sum of three months' worth of ratings.

CNC Financial Forecast

CNC Earnings Forecast

Next quarter’s earnings estimate for CNC is $0.10 with a range of $0.00 to $0.33. The previous quarter’s EPS was $2.51. CNC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.
Next quarter’s earnings estimate for CNC is $0.10 with a range of $0.00 to $0.33. The previous quarter’s EPS was $2.51. CNC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.

CNC Sales Forecast

Next quarter’s sales forecast for CNC is $47.12B with a range of $45.63B to $49.17B. The previous quarter’s sales results were $53.58B. CNC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.
Next quarter’s sales forecast for CNC is $47.12B with a range of $45.63B to $49.17B. The previous quarter’s sales results were $53.58B. CNC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CNC has Performed in-line its overall industry.

CNC Stock Forecast FAQ

What is CNC’s average 12-month price target, according to analysts?
Based on analyst ratings, Centene’s 12-month average price target is 72.92.
    What is CNC’s upside potential, based on the analysts’ average price target?
    Centene has 12.19% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CNC a Buy, Sell or Hold?
          Centene has a consensus rating of Moderate Buy which is based on 6 buy ratings, 8 hold ratings and 0 sell ratings.
            What is Centene’s price target?
            The average price target for Centene is 72.92. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $80.00 ,the lowest forecast is $65.00. The average price target represents 12.19% Increase from the current price of $65.
              What do analysts say about Centene?
              Centene’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of CNC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.